Notifications
Back
R & D

TeCure brings the future of healthcare

R&D
GOAL

We aim to develop and commercialize first-in-class medical devices that leverage advanced laser delivery technology for the safe and convenient treatment of diseases in tubular organs. 

ENDOSCOPIC LASER TECHNOLOGY

  • Uniform 360° Light Delivery Technology 
  • Catheter-Coupled Centering Technology 
  • Miniaturized Through-the-Scope (TTS) Design 
R&D
GOAL 

We aim to develop and commercialize first-in-class medical devices that leverage advanced laser delivery technology for the safe and convenient treatment of diseases in tubular organs.  

ENDOSCOPIC LASER TECHNOLOGY

  • Uniform 360° Light Delivery Technology
  • Catheter-Coupled Centering Technology
  • Miniaturized Through-the-Scope (TTS) Design

360° Lateral Light Delivery Technology 

By applying precision-engineered micro-lenses and total internal reflection angle control, laser light can be evenly delivered in a 360-degree lateral direction. 

Functional Catheter Integration Technology 

By combining functional structures with the optical applicator, it can be stably fixed within tubular tissues, enabling precise and safe endoscopic treatment. 

Through-the-Scope (TTS) Technology

By applying catheter miniaturization manufacturing, we implement a TTS system that can be inserted into the endoscopic channel, enhancing usability. 

Predictable Thermal Coagulation via Concentric Temperature Distribution 

The circumferential light distribution generates a concentric temperature profile around the optical applicator, enabling predictable thermal coagulation within soft tissues. 

Selective removal of the mucosal layer to protect surrounding tissues.

An endoscopic catheter can be used to ablate the duodenal mucosa with laser light via the through-the-scope (TTS) approach in a circumferential manner. Laser can selectively ablate a mucosa layer without thermal injury to adjacent tissue (submucosa and muscle layers).

Precise Bile Duct Resection via ERCP-Guided Laser 

ERCP-guided laser treatment using an endoscopic catheter enables circumferential resection of tubular tissue. The position of the catheter within the bile duct can be monitored through fluoroscopic imaging. The coagulative necrosis zone is confined to less than 1 mm. 

Selective Mucosal Layer Removal for Surrounding Tissue Protection 

Using an endoscopic catheter via the through-the-scope (TTS) approach, gastrointestinal mucosa can be circumferentially ablated with laser energy. The laser selectively removes only the mucosal layer without causing thermal damage to the surrounding tissues such as the submucosa and muscularis layers. 

Predictable Thermal Coagulation via Concentric Temperature Distribution


The circumferential light distribution generates a concentric temperature profile around the optical applicator, enabling predictable thermal coagulation within soft tissues.

Uniform Heating and Removal of Gastrointestinal Mucosal Tissue


When the surface of gastrointestinal mucosal tissue (a portion of the small intestine) is exposed to laser light, the temperature rises uniformly, enabling safe and precise ablation. Experimental results confirmed a noticeable reduction in mucosal thickness following laser treatment.

Precise Bile Duct Resection via ERCP-Guided Laser


ERCP-guided laser treatment using an endoscopic catheter enables circumferential resection of tubular tissue. The position of the catheter within the bile duct can be monitored through fluoroscopic imaging. The coagulative necrosis zone is confined to less than 1 mm.

Selective Muscular Layer Regression Confirmed via Real-Time Monitoring


Gastrointestinal endoscopy allows monitoring of concentric laser treatment of the esophageal muscle using an endoscopic catheter. The laser system continuously measures the surface temperature of the tissue in real time. Histological analysis confirmed selective tissue regression in the muscle layer without damaging the mucosal layer.

Company Name TeCure, Inc
CEO   Hyun Wook Kang 

Address   307 Hanmir Hall, 365 Sinseon-ro,

Nam-gu, Busan, Korea　
Tel  +82-51-629-5774 　

Privacy Policy   I   Terms of Use   I   Careers

Copyright  © 2025  TeCure. All rights reserved 

 Company  TeCure, Inc　CEO Hyun Wook Kang

 Address 307 Hanmir Hall, 365 Sinseon-ro, Nam-gu, Busan, Korea　 Tel +82-51-629-5774　 

 Privacy Policy     |     Terms of Use     |     Careers 

 Copyright © 2025 TeCure. All rights reserved. 

Brand Page
테스트1
테스트2
테스트3